Shanghai Serum Bio-Technology Co., Ltd. (SHA:688163)
China · Delayed Price · Currency is CNY 35.72
+0.17 (0.48%)
Sep 1, 2026, 4:00 PM EDT
SHA:688163 Market Cap
SHA:688163 has a market cap or net worth of 3.87 billion as of September 1, 2026. Its market cap has increased by 45.14% in one year.
Market Cap
3.87B
Enterprise Value
3.13B
Revenue
199.60M
Ranking
n/a
PE Ratio
70.14
Stock Price
35.72
ChartMarket Cap Chart
Since March 11, 2022, SHA:688163's market cap has decreased from 5.98B to 3.87B, a decrease of -35.41%. That is a compound annual growth rate of -9.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 3.87B | 64.08% |
| Dec 31, 2025 | 2.36B | 23.97% |
| Dec 31, 2024 | 1.90B | -12.16% |
| Dec 29, 2023 | 2.16B | -5.22% |
| Dec 30, 2022 | 2.28B | -61.86% |
| Mar 11, 2022 | 5.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Anhui Huaheng Biotechnology | 4.23B |
| Shanghai Obio Technology (Group) Corp. | 4.21B |
| Beijing Bohui Innovation Biotechnology Group | 4.19B |
| Xiangxue Pharmaceutical | 4.15B |
| Kexing Biopharm | 4.11B |
| Hefei Lifeon Pharmaceutical | 4.09B |
| Jiangsu Sihuan Bioengineering | 3.99B |
| Beijing Scitop Bio-tech | 3.84B |